Brief: Interpace Biosciences Says Investigation By Audit Committee Finds No Evidence Of Any "Illegal Acts"
Oct 14 (Reuters) - Interpace Biosciences Inc IDXG.O :
* INTERPACE BIOSCIENCES - AUDIT COMMITTEE OF BOARD COMPLETED
INDEPENDENT INVESTIGATION INTO COMPLAINTS OF SOME EMPLOYMENT AND
BILLING MATTERS
* INTERPACE BIOSCIENCES - COMMITTEE CONCLUDED THAT THERE WAS
NO
EVIDENCE OF ANY "ILLEGAL ACTS"
Source text for Eikon: ID:nGNX1Jmtqy
Further company coverage: IDXG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million